Critical Issues America Annual Conference -April 8-9 2022

*This year's meeting is being planned as an In-Person meeting only.


Due to Omicron - This years meeting has been postponed to April 8-9, 2022

All previous registrations have been contacted and moved to the April date.

Please adjust your travel and hotel arrangements match the April 8-9, 2022 dates

*Covid-19 Pandemic Update --  The recent COVID situation in the United States has made in-person meetings difficult at this time.  Consequently the directors of this meeting have decided to postpone until April 8-9, 2022.

*Make sure any travel arrangements are refundable because conditions could warrant further limitations or cancellation of the on-site option.  Masking requirements will follow local regulations and hotel guidelines and every seat will be properly distanced.  Attendees will be subject to health monitoring such as temperature checks.

We invite you to attend our annual CRITICAL ISSUES america (CIA) meeting. The meeting will help participants to identify & manage complications associated with endovascular and open repair of complex aortic disease including: arch descending thoracic, TAAA, pararenal & juxtarenal aneurysms, aortoiliac aneurysms and other miscellaneous pathologies affecting the aorta.

The Biltmore Hotel April 8-9, 2022

1200 Anastasia Avenue | Coral Gables, Florida 33134

CIA will recognize potential treatment failure and the role of advance imaging techniques in the evaluation, treatment, and management of aortic disease.


Target Audience

The target audience includes physicians who specialize in vascular surgery, cardiology, interventional radiology, vascular medicine, cardiothoracic surgery, as well as fellows, and allied health professionals.



  • Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
  • Discuss new developments in basic, translational and biomaterial research that impact DLE management
  • Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
  • Identify possible areas of collaboration between academia and industry
  • Physician......................................$395
  • Non-Physician...............................$195
  • Resident/Fellow............................$Free

Our 2021 Sponsors